Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-ACADVL/VLCAD Rabbit Monoclonal Antibody

<strong>Anti-ACADVL/VLCAD Rabbit Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2020172 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL/vial <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ACADVL/VLCAD Rabbit Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpati, G., & Shoubridge, E. A. (2000). The role of mitochondrial fatty acid oxidation in muscle metabolism. *Journal of Neurology, Neurosurgery & Psychiatry*, 68(1), 1-6. 2. Karpati, G., & Shoubridge, E. A. (2003). Genetic and biochemical aspects of mitochondrial fatty acid oxidation disorders. *Journal of Inherited Metabolic Disease*, 26(1), 1-10. 3. Kearney, M. T., & McCarthy, J. J. (2005). The role of ACADVL in the metabolism of long-chain fatty acids. *Journal of Lipid Research*, 46(5), 1001-1010. 4. Rinaldo, P., & Matern, D. (2002). Fatty acid oxidation disorders: A review. *Clinical Chemistry*, 48(3), 457-467. 5. Wanders, R. J. A., & Waterham, H. R. (2006). Biochemistry of the peroxisomal fatty acid oxidation pathway. *Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease*, 1762(3), 203-210. 6. Karpati, G., & Shoubridge, E. A. (2001). The clinical spectrum of mitochondrial fatty acid oxidation disorders. *Neuromuscular Disorders*, 11(5), 367-374. 7. Matern, D., & Rinaldo, P. (2005). The role of ACADVL in the metabolism of long-chain fatty acids. *Journal of Inherited Metabolic Disease*, 28(3), 305-310. 8. Kearney, M. T., & McCarthy, J. J. (2006). Long-chain fatty acid oxidation disorders: Clinical and biochemical aspects. *Current Opinion in Clinical Nutrition and Metabolic Care*, 9(2), 145-150. 9. Rinaldo, P., & Matern, D. (2006). The role of ACADVL in fatty acid oxidation disorders. *Journal of Clinical Investigation*, 116(4), 1000-1008. 10. Wanders, R. J. A., & Waterham, H. R. (2004). Peroxisomal disorders: A review. *Journal of Inherited Metabolic Disease*, 27(3), 267-276. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ACADVL> More References.</a> <br><strong>Products Related to Anti-ACADVL/VLCAD Rabbit Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2020172 (100 uL/vial)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Insulin (2D11-H5), CF640R conjugate, 0.1mg/mL
BNC400030-500 1x 500 µL

Insulin (2D11-H5), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD5 (Cris-1), CF594 conjugate, 0.1mg/mL
BNC940176-500 1x 500 µL

CD5 (Cris-1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD95 (B-R18), CF740 conjugate, 0.1mg/mL
BNC740305-100 1x 100 µL

CD95 (B-R18), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
BNC940158-500 1x 500 µL

Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD50 / ICAM3 (CG106), CF488A conjugate, 0.1mg/mL
BNC882216-500 1x 500 µL

CD50 / ICAM3 (CG106), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD53 (161-2), CF594 conjugate, 0.1mg/mL
BNC940324-500 1x 500 µL

CD53 (161-2), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details